Navigation Links
Marco Romano, MD Joins Chiltern as Medical Director, Europe
Date:10/2/2007

LONDON, Oct. 3 /PRNewswire/ -- Chiltern, a leading global clinical research organization, has announced the appointment of Marco Romano, MD to the role of Medical Director, Europe. Dr. Romano has over 19 years of experience in both the Pharmaceutical and CRO Industries where he held executive-level positions, most recently with a large USA based CRO.

Dr. Romano earned his MD at the University of Genova, Italy, and he also holds a post-graduate degree in Hygiene, Epidemiology and Public Health from the University of Genova and a post-graduate degree in Clinical Pharmacology from the University of Milan. Dr Romano co-authored several scientific papers on mutagenesis and cancerogenesis, pharmacokinetics and pharmacodynamics of chemical compounds and glutathione metabolism.

Dr. Romano will be located in the company's Milan office. He will be responsible for the European medical department as well as heading one of our Global Therapeutic Area Teams. Dr. Romano will also focus on providing medical and scientific expertise to sponsors regarding product development and product life cycle management strategies. Dr Romano is closely connected to the Italian Pharmaceutical sector and will soon be President of SSFA, an influential medical association in Italy. His extensive experience and network will lead to the further development of our Italian operations.

"I am very pleased to join Chiltern," said Marco. "The global medical team is very strong and I look forward to working with them, our sponsors and our therapeutic focused teams."

"I am delighted that Marco has joined Chiltern," commented Lewis Cameron, Executive Vice President, Europe. "Marco's strong industry background and overall in-depth experience in clinical research will add to the dedicated medical and therapeutic teams already in place."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience of running a
'/>"/>

SOURCE Chiltern
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Check if your “Favourite medical web-site” is indulging in Quackey
10. Teens turning to Internet for medical queries
11. Robots craft medical history

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...onAdBuyTargetingAK,AR,FL,IN,LA,ME,NE,NDandSD ,...InthewakeoftheSenate,svoteonSaturdaytotakeupthehea...announcedanewadvertisingcampaigntargetingSenatorsi...ana,Maine,Nebraska,NorthDakota,andSouthDakota. ,...reandMedicaidServices(CMS)reportwhichconfirmscutst...
(Date:11/24/2009)....24/PRNewswire/--Metastorm,aleadingproviderofBusin...BPA),andEnterpriseArchitecture(EA)softwareforalign...AmerisourceBergenCorporation,oneoftheworld,slarges...ardforNorthAmericainthe2009GlobalAwardsforExcellen...simplementationofMetastorm,sBPMsoftware.Theawardre...
(Date:11/24/2009)...Nov.24/PRNewswire/--Thankstoaninnovativeprogramrec...(EMHS)andAnthemBlueCrossandBlueShieldinMaine,someA...irphysicianwithoutleavinghome. ,, Aspartofthepi...sandquestionsandcommunicateviaemailwiththeirprovid...pointments,checkingontestresults,orrequestingpresc...
(Date:11/24/2009)...ailable in French and Spanish . , Researc...uicide gene, called ,gene E, which leads to the d... colon cancer, and prevents their growth. The impo...ancer can reduce the potent drugs that are current...nt for cancer. , This research was conducted by ...
(Date:11/24/2009)...ailable in German . , Internationally viewe...r is very good as far as survival is concerned. Ho...n, and long-term consequences of the disease are s...is the conclusion of the Institute for Quality and...port published on 16 October 2009. , Establish ...
Breaking Medicine News(10 mins):Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2Health News:The Doctor Will See You Now. . .Online 2Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3
...nd between when a couple has sex and any subsequen...mal studies have suggested that the timing of sex ...ing.// Dr. Joe Leigh Simpson, a professor of ...ects in lower animals. Researchers have post...
...y of Michigan, have found a gene which acts as a s...ng a technique called DNA microarray analysis, whi...ds of different genes in tissue samples. //The gen... 90 per cent of 200 prostate cancer tissue samples...
...ethod of compressing DNA which could make gene the...d out on cystic fibrosis patients, may allow the m...A single strand of DNA contains a complete bluepri...ified DNA strands into the cells they want to chan...
... high levels of a hormone called Leptin, produced ...lly lethal blood clots. Researchers at the Univers...o develop dangerous blood clots, but the relations...ssistant professor of internal medicine, studied v...
...research, the liver is a neglected key. Professor ...spital, felt that there are many wonderful things ... pharmacology and toxicology.//Your mortgage is pa... would be fine if it wasn't for dementia, arthriti...
...lp to reduce the risk of heart disease. Researcher...ments had nearly one-third less risk of dying from...amin D have been associated with increased risk of... standard therapy for the bone-thinning disease os...
Other Medicine News:Health News:Liver key to extending life 2
(Date:11/23/2009)....23/PRNewswire-USNewswire/--FebeDurango-Rueda,52,a...ticipatinginaschemetodefraudtheExport-ImportBankof...uncedAssistantAttorneyGeneraloftheCriminalDivision...tacosoftheEx-ImBank,OfficeoftheInspectorGeneral. ,...tsinU.S.DistrictCourtinWashingtontoaone-countcrimi...
(Date:11/23/2009)...3/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: N...uctsforminimallydisruptivesurgicaltreatmentsforthe...iefExecutiveOfficer,andMichaelJ.Lambert,ExecutiveV...opresentatthe21stAnnualPiperJaffrayHealthCareConfe...ay,December2,2009,at10:00a.m.ET.Mr.LukianovandMr.L...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--WestPharmaceuticalSe...y,sChiefOperatingOfficerMatthewT.Mullarkeyhasleftt...erChiefOperatingOfficerStevenA.Ellers,58,willdefer...demanagerialcontinuityandsupportfollowingMr.Mullar...balmanufacturerofcomponentsandsystemsforinjectable...
Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 3St Gallen consensus 2009 3A A radically different approach to treating early breast cancer 49311 1St Gallen consensus 2009 3A A radically different approach to treating early breast cancer 49311 2St Gallen consensus 2009 3A A radically different approach to treating early breast cancer 49311 3Epilepsy Services on the Chopping Block 49309 1Epilepsy Services on the Chopping Block 49309 2Mayo Clinic Plans Facility at Mall of America 49306 1Mayo Clinic Plans Facility at Mall of America 49306 2Mayo Clinic Plans Facility at Mall of America 49306 3
...Jun 21, 2007 - Nymox,Pharmaceutical Corporation (N... from the Company,s recently completed studies of,...l be presented at,a series of upcoming U.S. urolog...ntral American Urological Association Meeting in,C...tions will be,given by leading clinical research u...
...“In anaplastic,astrocytoma, AP 12009 as a mo...mide,” Prof. Albert Wong, M.D., Stanford,Uni...national Phase,IIb study with the TGF-beta 2-inhib...ma. Prof. Wong discussed the results of the study,...s system tumors,at the 43rd Annual Meeting of the ...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
Head-worn Loupes L
Head-worn Loupe G3
...age delivers higher magnification for advanced sur...risp, true image, even at the highest magnificatio...recise color rendition is ideal for surgical appli...lective coating produce a superior image. The comp...
...age delivers higher magnification for advanced sur...risp, true image, even at the highest magnificatio...recise color rendition is ideal for surgical appli...lective coating produce a superior image. The comp...
Medicine Products: